JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (1): 69-74.doi: 10.6040/j.issn.1671-7554.0.2016.1313

Previous Articles     Next Articles

Expression and clinical significance of microRNA-183 in polycystic ovary syndrome with insulin resistance

LI Jingbo, LIU Hongbin, JIA Yueyue, WANG Ze, SUN Mei, SHI Yuhua   

  1. Center for Reproductive Medicine, Shandong University;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics;
    Key Laboratory for Reproductive Endocrinology(Shandong University), Ministry of Education;
    Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan 250001, Shandong, China
  • Received:2016-10-14 Online:2017-01-10 Published:2017-01-10

PDF (PC)

172

Abstract: Objective To explore the expression of microRNA-183(miR-183)in the ovarian granulosa cells of polycystic ovary syndrome(PCOS)patients with insulin resistance(IR), and to evaluate its clinical significance. Methods A total of 120 PCOS patients including 78 with insulin resistance and 42 without, and 72 healthy controls were enrolled. The miR-183 expression was examined by real-time quantitative reverse transcription PCR(qRT-PCR). The correlation between miR-183 and homeostasis model assessment-insulin resistance(HOMA-IR)was analyzed. The area under the receiver operating characteristic(ROC)curve(AUC)was calculated to evaluate the predictive power of miR-183 for PCOS insulin resistance. Results PCOS patients with insulin resistance had higher miR-183 expression than the control group(P<0.001)and PCOS without insulin resistance group(P=0.034). There was positive correlation 山 东 大 学 学 报 (医 学 版)55卷1期 -李婧博,等.microRNA-183在PCOS胰岛素抵抗中的表达及其临床意义 \=-between HOMA-IR and miR-183 expression in PCOS with insulin resistance group(r=0.476, P=0.003). The ROC analysis suggested that combination of miR-183 and body mass index(BMI)(AUC: 0.820, 95%CI: 0.750-0.889, P<0.001)might be an effective indicator. Conclusion The high expression of miR-183 is correlated to insulin resistance of PCOS and HOMA-IR, and may be involved in the pathogenesis of PCOS insulin resistance through follicular microenvironment.

Key words: MicroRNA-183, Insulin resistance, Granulosa cell, Polycystic ovary syndrome

CLC Number: 

  • R711.75
[1] Pertynska-Marczewska M, Diamanti-Kandarakis E, Zhang J, et al. Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?[J]. Metabolism, 2015, 64(11): 1564-1573.
[2] Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome[J]. J Endocrinol Invest, 2016, 10. 1007/s40618-016-0523-8
[3] Ciaraldi TP, Aroda V, Mudaliar S, et al. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance[J]. J Clin Endocrinol Metab, 2009, 94(1): 157-163.
[4] 李晏丽, 宁光. microRNA与胰岛素抵抗[J]. 国际内分泌代谢杂志, 2014, 34(3): 188-190. LI Yanli, NING Guang. Relationship between microRNA and insulin resistance[J]. International Journal of Endocrinology and Metabolism, 2014, 34(3): 188-190.
[5] Gebremedhn S, Salilew-Wondim D, Hoelker M, et al. MicroRNA-183~96~182 cluster regulate bovine granulosa cell proliferation and cell cycle transition by coordinately targeting FOXO1[J]. Biol Reprod, 2016, 94(6): 127.
[6] Motino O, Frances DE, Mayoral R, et al. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-Box helicase p68(DDX5)dependent: role in insulin signaling[J]. Mol Cell Biol, 2015, 35(14): 2554-2567.
[7] Kaur S, Archer KJ, Devi MG, et al. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis[J]. J Clin Endocrinol Metab, 2012, 97(10): E2016-2021.
[8] Rotterdam ESHRE/AS RM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(1): 19-25.
[9] Matsubara H, Ikuta K, Ozaki Y, et al. Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells[J]. J Clin Endocrinol Metab, 2000, 85(4): 1620-1626.
[10] Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus[J]. Fertil Steril, 2002, 77(6): 1095-1105.
[11] Shi Y, Cui Y, Sun X, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 173: 66-70.
[12] Orio F, Vuolo L, Palomba S, et al. Metabolic and cardiovascular consequences of polycystic ovary syndrome[J]. Minerva Ginecol, 2008, 60(1): 39-51.
[13] Xu X, Zhao H, Shi Y, et al. Family association study between INSR gene polymorphisms and PCOS in Han Chinese[J]. Reprod Biol Endocrinol, 2011, 9: 76.
[14] 张文娟, 吴兴国, 丁明德, 等. 脂联素基因多态性与多囊卵巢综合征发病关系的病例对照研究[J]. 中华妇产科杂志, 2015, 50(11): 825-829. ZHANG Wenjuan, WU Xingguo, DING Mingde, et al. Case-control based study between polymorphisms in the adiponectin gene and polycystic ovary syndrome[J]. Chinese Journal of Obstetrics and Gynecology, 2015, 50(11): 825-829.
[15] Hackbart KS, Cunha PM, Meyer RK, et al. Effect of glucocorticoid-induced insulin resistance on follicle development and ovulation[J]. Biol Reprod, 2013, 88(6): 153.
[16] Turner N, Robker RL. Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role?[J]. Mol Hum Reprod, 2015, 21(1): 23-30.
[17] Flynt AS, Lai EC. Biological principles of microRNA-mediated regulation: shared themes amid diversity[J]. Nat Rev Genet, 2008, 9(11): 831-842.
[18] Imbar T, Eisenberg I. Regulatory role of microRNAs in ovarian function[J]. Fertil Steril, 2014, 101(6): 1524-1530.
[19] Pierce ML, Weston MD, Fritzsch B, et al. MicroRNA-183 family conservation and ciliated neurosensory organ expression[J]. Evol Dev, 2008, 10(1): 106-113.
[20] Chen H, Zhang L, Zhang L, et al. MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner[J]. Am J Transl Res, 2016, 8(4): 1748-1755.
[21] Baran-Gale J, Fannin EE, Kurtz CL, et al. Beta cell 5'-shifted isomiRs are candidate regulatory hubs in type 2 diabetes[J]. PLoS One, 2013, 8(9): e73240.
[22] Jeon TI, Esquejo RM, Roqueta-Rivera M, et al. An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis[J]. Cell Metab, 2013, 18(1): 51-61.
[23] Xu J, Wong C. A computational screen for mouse signaling pathways targeted by microRNA clusters[J]. RNA, 2008, 14(7): 1276-1283.
[24] Ding L, Gao F, Zhang M, et al. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome[J]. Fertil Steril, 2016, 105(5): 1330-1337
[25] Makker A, Goel MM, Mahdi AA. PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update[J]. J Mol Endocrinol, 2014, 53(3): R103-118.
[26] Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease[J]. Nat Rev Genet, 2009, 10(4): 233-240.
[1] ZHANG Yuan, LI Yang-Min, FENG Rue-Qiu, CHANG Cai-Yun, PAN Hua-Wei, WANG Shu-Mei. Relationship among serum adiponectin level, obesity and insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 124-.
[2] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60-66.
[3] ZHANG Suping, WANG Ze, ZHOU Yali, LI Jing, LU Xilan, BAI Hongwei, SHI Yuhua. Clinical effects of body mass index on ovulation induction treatment with letrozole among women with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 81-85.
[4] LI Jian, XU Bing, YAN Xinfeng, XU Wanju, CHANG Xiaotian. Screening key genes for TXNDC5 and insulin signaling pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 88-93.
[5] LI Hongzhi, SHEN Yongchao, LIU Jieting, ZHAO Xiaojin, CHU Yanhui, YUAN Xiaohuan. An 11β-HSD1 inhibitor improves insulin sensitivity in db/db mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 59-64.
[6] YANG Dongzi, MAI Zhuoyao. Features of ovarian reserve and outcomes of assisted reproductive technology in elder patients with PCOS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 26-32.
[7] JIA Yueyue, LIU Hongbin, LI Jingbo, LI Jing, ZHANG Jiangtao, SUN Mei, SHI Yuhua. Expression of microRNA-200b in granulosa cells of PCOS patients and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 63-68.
[8] ZHANG Lin, LI Jing, WANG Ze, ZHANG Jiangtao, MA Zengxiang, SHI Yuhua. Impact of thyroid-stimulating hormone on blood glucose and serum lipids in patients with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 80-84.
[9] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[10] MA Huiming, ZHANG Yongfang, WANG Mengmeng, LI Xin, WANG Yongfeng, TIAN Hongcheng, HU Rong, WANG Yanrong, PEI Xiuying, XU Xian. Effect of estrogen on expression of estrogen receptor-β and forkhead transcription factor 3 in human granulosa cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 50-55.
[11] XU Yibo, JI Xiaokang, LI Xiangyi, SHEN Zhenwei, XUE Fuzhong. Analysis on the relationship between urine pH and metabolic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 82-85.
[12] JIANG Fangjie, SHAO Shanshan, JING Fei, YU Chunxiao, ZHAO Jiajun. Fat-derived adipokine disorder in high cholesterol diet rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(11): 1-5.
[13] HAN Wenjie1, YU Suguo1, CUI Xiangyu2. Effects of N-acetylcysteine on GLP-1 and IL-6 in high-fat-diet rats with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 12-16.
[14] WANG Chuan1, HOU Xinguo1, LIANG Kai1, YAN Fei1, YANG Junpeng1, WANG Lingshu1, TIAN Meng1, LI Chengqiao2, ZHANG Xiuping3, YANG Weifang4, MA Zeqiang5, CHEN Li1. HDL-C and TG/HDL-C ratio to identify insulin resistance in middle-aged and older Hui ethnic population in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 73-76.
[15] ZHANG Yanling1, ZHANG Xu1, ZHANG Wenwen1, WANG Furong2, YU Chunxiao1, GUAN Qingbo1, YU Guina1, GAO Ling3, ZHAO Jiajun1, XU Jin1. Relationship between serum level of 25-hydroxyvitamin D and fasting blood glucose in healthy adults of Jinan [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 59-63.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd